Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1022

1.

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.

Weiss A, Menen RS, Lin HY, Shen Y, Rosso KJ, Shaitelman S, Woodward W, Valero V, Ueno NT, Bedrosian I, Babiera G.

Breast Cancer Res Treat. 2018 Feb 19. doi: 10.1007/s10549-018-4715-0. [Epub ahead of print]

PMID:
29460033
2.

A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.

Tanaka K, Fujiya M, Ijiri M, Takahashi K, Ando K, Nomura Y, Ueno N, Kashima S, Goto T, Sasajima J, Ito T, Moriichi K, Mizukami Y, Tanabe H, Okumura T.

J Gastrointest Cancer. 2018 Feb 19. doi: 10.1007/s12029-018-0078-3. [Epub ahead of print] No abstract available.

PMID:
29457212
3.

Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications.

He J, Huo L, Ma J, Zhao J, Bassett RL, Sun X, Ueno NT, Lim B, Gong Y.

Am J Clin Pathol. 2018 Feb 7. doi: 10.1093/ajcp/aqx162. [Epub ahead of print]

PMID:
29425258
4.

Intracellular calcium signal at the leading edge regulates mesodermal sheet migration during Xenopus gastrulation.

Hayashi K, Yamamoto TS, Ueno N.

Sci Rep. 2018 Feb 5;8(1):2433. doi: 10.1038/s41598-018-20747-w.

5.

Elucidation of the electronic states in polyethylene glycol by attenuated Total reflectance spectroscopy in the far-ultraviolet region.

Ueno N, Wakabayashi T, Morisawa Y.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jan 30. pii: S1386-1425(18)30057-X. doi: 10.1016/j.saa.2018.01.042. [Epub ahead of print]

PMID:
29395931
6.

An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.

Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, Sakatani A, Tanaka K, Nomura Y, Ueno N, Kashima S, Moriichi K, Mizukami Y, Kohgo Y, Okumura T.

BMC Cancer. 2018 Jan 31;18(1):116. doi: 10.1186/s12885-018-4006-5.

7.

[Early Surgery for Acute Cholecystitis Complicated with Gallbladder Cancer].

Tamura T, Yoshikawa T, So S, Maeda T, Wakahara T, Kanemitsu K, Tsuchida S, Ueno N, Toyokawa A.

Gan To Kagaku Ryoho. 2018 Jan;45(1):112-114. Japanese.

PMID:
29362325
8.

Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?

Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, Toyokawa A.

Gastroenterology Res. 2017 Dec;10(6):359-365. doi: 10.14740/gr943w. Epub 2018 Jan 3.

9.

Toxoplasma gondii disrupts β1 integrin signaling and focal adhesion formation during monocyte hypermotility.

Cook JH, Ueno N, Lodoen MB.

J Biol Chem. 2018 Jan 2. pii: jbc.M117.793281. doi: 10.1074/jbc.M117.793281. [Epub ahead of print]

10.

Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.

Arun BK, Gutierrez Barrera AM, Ueno NT.

Cancer. 2018 Feb 15;124(4):866. doi: 10.1002/cncr.31188. Epub 2017 Dec 19. No abstract available.

PMID:
29266209
11.

[Granulomatosis with Polyangiitis Complicated with Gastrointestinal Perforation: A Case Report and Review of Literature].

Kiboshi T, Isoda K, Furukawa K, Wakahara T, Otani K, Ueda K, Konma J, Teramura K, Ueno N, Fujiwara H, Shoda T.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(5):382-386. doi: 10.2177/jsci.40.382. Review. Japanese.

12.

Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.

Fujii T, Matsuda N, Kono M, Harano K, Chen H, Luthra R, Roy-Chowdhuri S, Sahin AA, Wathoo C, Joon AY, Tripathy D, Meric-Bernstam F, Ueno NT.

Eur J Cancer. 2018 Jan;89:64-71. doi: 10.1016/j.ejca.2017.11.015. Epub 2017 Dec 9.

PMID:
29232568
13.

Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia.

Ueno N.

J Clin Med Res. 2017 Dec;9(12):1007-1012. doi: 10.14740/jocmr3219w. Epub 2017 Nov 6.

14.
15.

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes.

Masuda H, Qi Y, Liu S, Hayashi N, Kogawa T, Hortobagyi GN, Tripathy D, Ueno NT.

Oncotarget. 2017 Jul 31;8(41):70481-70495. doi: 10.18632/oncotarget.19719. eCollection 2017 Sep 19.

16.

Impact of Gastric Cancer Surgery in Elderly Patients.

Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, Toyokawa A.

Oncology. 2017 Oct 19. doi: 10.1159/000481404. [Epub ahead of print]

PMID:
29045948
17.

Proper training in laparoscopic hernia repair is necessary to minimize the rising recurrence rate in Japan.

Matsumoto S, Hayakawa T, Kawarada Y, Uchida K, Eguchi T, Wada H, Ueno N, Idani H, Nakano K, Oomomo Y.

Asian J Endosc Surg. 2017 Oct 17. doi: 10.1111/ases.12433. [Epub ahead of print]

PMID:
29045057
18.

BRCA mutations in women with inflammatory breast cancer.

Gutierrez Barrera AM, Fouad TM, Song J, Webster R, Elsayegh N, Wood AL, Demir A, Litton JK, Ueno NT, Arun BK.

Cancer. 2018 Feb 1;124(3):466-474. doi: 10.1002/cncr.31069. Epub 2017 Oct 17.

PMID:
29044548
19.

Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.

Schvartsman G, Gutierrez-Barrera AM, Song J, Ueno NT, Peterson SK, Arun B.

Cancer Med. 2017 Nov;6(11):2515-2522. doi: 10.1002/cam4.1207. Epub 2017 Oct 10.

20.

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.

Wang X, Reyes ME, Zhang D, Funakoshi Y, Trape AP, Gong Y, Kogawa T, Eckhardt BL, Masuda H, Pirman DA Jr, Yang P, Reuben JM, Woodward WA, Bartholomeusz C, Hortobagyi GN, Tripathy D, Ueno NT.

Oncotarget. 2017 Jul 4;8(40):67904-67917. doi: 10.18632/oncotarget.18958. eCollection 2017 Sep 15.

21.

Clinicopathological study of a dimorphic variant of breast carcinoma.

Ueno N, Kuroda H, Kurosumi M, Kozuka Y, Ito J, Kato H, Kubota K, Imai Y.

Breast Cancer. 2018 Mar;25(2):151-158. doi: 10.1007/s12282-017-0804-x. Epub 2017 Sep 30.

PMID:
28965222
22.

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.

Fujii T, Kogawa T, Dong W, Sahin AA, Moulder S, Litton JK, Tripathy D, Iwamoto T, Hunt KK, Pusztai L, Lim B, Shen Y, Ueno NT.

Ann Oncol. 2017 Oct 1;28(10):2420-2428. doi: 10.1093/annonc/mdx397.

PMID:
28961844
23.

Androgen receptor expression on circulating tumor cells in metastatic breast cancer.

Fujii T, Reuben JM, Huo L, Espinosa Fernandez JR, Gong Y, Krupa R, Suraneni MV, Graf RP, Lee J, Greene S, Rodriguez A, Dugan L, Louw J, Lim B, Barcenas CH, Marx AN, Tripathy D, Wang Y, Landers M, Dittamore R, Ueno NT.

PLoS One. 2017 Sep 28;12(9):e0185231. doi: 10.1371/journal.pone.0185231. eCollection 2017.

24.

Outcomes of Consistent Conservative Management for Acute Cholecystitis Followed by Delayed Cholecystectomy.

Komatsu S, Tsuchida S, Wakahara T, Ueno N, Toyokawa A, Watanabe A, Sugahara A, Mukai H.

Surg Laparosc Endosc Percutan Tech. 2017 Oct;27(5):404-408. doi: 10.1097/SLE.0000000000000458.

PMID:
28906420
25.

Thrombocytosis as a prognostic factor in inflammatory breast cancer.

Harano K, Kogawa T, Wu J, Yuan Y, Cohen EN, Lim B, Reuben JM, Ueno NT.

Breast Cancer Res Treat. 2017 Dec;166(3):819-832. doi: 10.1007/s10549-017-4463-6. Epub 2017 Aug 22.

PMID:
28831670
26.

Impact of Statin Use on Outcomes in Triple Negative Breast Cancer.

Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA.

J Cancer. 2017 Jul 5;8(11):2026-2032. doi: 10.7150/jca.18743. eCollection 2017.

27.

Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation.

Bashour SI, Doostan I, Keyomarsi K, Valero V, Ueno NT, Brown PH, Litton JK, Koenig KB, Karuturi M, Abouharb S, Tripathy D, Moulder-Thompson SL, Ibrahim NK.

J Cancer. 2017 Jul 5;8(11):2004-2009. doi: 10.7150/jca.18196. eCollection 2017.

28.

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival.

Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, Ueno NT, Brewster AM, Woodward WA.

J Cancer. 2017 Jul 1;8(10):1726-1732. doi: 10.7150/jca.20095. eCollection 2017.

29.

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Arango NP, Yuca E, Zhao M, Evans KW, Scott S, Kim C, Gonzalez-Angulo AM, Janku F, Ueno NT, Tripathy D, Akcakanat A, Naing A, Meric-Bernstam F.

Breast Cancer Res. 2017 Aug 15;19(1):93. doi: 10.1186/s13058-017-0878-6.

30.

Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.

Tanaka K, Fujiya M, Sakatani A, Fujibayashi S, Nomura Y, Ueno N, Kashima S, Goto T, Sasajima J, Moriichi K, Okumura T.

Ann Clin Microbiol Antimicrob. 2017 Aug 14;16(1):54. doi: 10.1186/s12941-017-0230-0.

31.

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.

Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A.

Ann Surg Oncol. 2017 Oct;24(10):2981-2988. doi: 10.1245/s10434-017-5952-x. Epub 2017 Aug 1.

PMID:
28766220
32.

Hole-phonon coupling effect on the band dispersion of organic molecular semiconductors.

Bussolotti F, Yang J, Yamaguchi T, Yonezawa K, Sato K, Matsunami M, Tanaka K, Nakayama Y, Ishii H, Ueno N, Kera S.

Nat Commun. 2017 Aug 2;8(1):173. doi: 10.1038/s41467-017-00241-z.

33.

Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.

DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A.

Clin Breast Cancer. 2018 Feb;18(1):e73-e77. doi: 10.1016/j.clbc.2017.06.014. Epub 2017 Jul 10.

PMID:
28755879
34.

Novel therapeutic strategies in the treatment of triple-negative breast cancer.

Oualla K, El-Zawahry HM, Arun B, Reuben JM, Woodward WA, Gamal El-Din H, Lim B, Mellas N, Ueno NT, Fouad TM.

Ther Adv Med Oncol. 2017 Jul;9(7):493-511. doi: 10.1177/1758834017711380. Epub 2017 Jun 13. Review.

35.

In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC.

Rosso KJ, Ueno NT, Woodward WA, Lucci A.

Breast Cancer Res Treat. 2017 Oct;165(3):779-781. doi: 10.1007/s10549-017-4337-y. Epub 2017 Jul 3. No abstract available.

PMID:
28674763
36.

Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.

Tanabe H, Ando K, Sato K, Ito T, Goto M, Sato T, Fujinaga A, Kawamoto T, Utsumi T, Yanagawa N, Ichiishi E, Otake T, Kohgo Y, Nomura Y, Ueno N, Sugano H, Kashima S, Moriichi K, Fujiya M, Okumura T.

Dig Dis Sci. 2017 Nov;62(11):3069-3076. doi: 10.1007/s10620-017-4664-1. Epub 2017 Jun 29. Review.

PMID:
28664410
37.

Ferrichrome identified from Lactobacillus casei ATCC334 induces apoptosis through its iron-binding site in gastric cancer cells.

Ijiri M, Fujiya M, Konishi H, Tanaka H, Ueno N, Kashima S, Moriichi K, Sasajima J, Ikuta K, Okumura T.

Tumour Biol. 2017 Jun;39(6):1010428317711311. doi: 10.1177/1010428317711311.

PMID:
28639907
38.

Measurement of surface topography and stiffness distribution on cross-section of Xenopus laevis tailbud for estimation of mechanical environment in embryo.

Murakami F, Ando Y, Miyagi A, Sugita S, Ueno N, Matsumoto T.

Dev Growth Differ. 2017 Jun;59(5):434-443. doi: 10.1111/dgd.12372. Epub 2017 Jun 19.

PMID:
28627765
39.

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).

Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL.

Neoplasia. 2017 Jul;19(7):564-573. doi: 10.1016/j.neo.2017.03.002. Epub 2017 Jun 10.

40.

Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells.

Daquinag AC, Dadbin A, Snyder B, Wang X, Sahin AA, Ueno NT, Kolonin MG.

Mol Ther Oncolytics. 2017 May 17;6:1-9. doi: 10.1016/j.omto.2017.05.003. eCollection 2017 Sep 15.

41.

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer.

Sato N, Wakabayashi M, Nakatsuji M, Kashiwagura H, Shimoji N, Sakamoto S, Ishida A, Lee J, Lim B, Ueno NT, Ishihara H, Inui T.

Biochem Biophys Res Commun. 2017 Aug 5;489(4):484-489. doi: 10.1016/j.bbrc.2017.05.177. Epub 2017 May 30.

42.

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status.

Hayashi N, Iwamoto T, Qi Y, Niikura N, Santarpia L, Yamauchi H, Nakamura S, Hortobagyi GN, Pusztai L, Symmans WF, Ueno NT.

J Cancer. 2017 Apr 9;8(6):1045-1052. doi: 10.7150/jca.13690. eCollection 2017.

43.

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.

Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N.

J Cancer. 2017 Mar 25;8(6):1009-1017. doi: 10.7150/jca.16870. eCollection 2017.

44.

Pilot study of endoscopic retrograde 3-dimensional - computed tomography enteroclysis for the assessment of Crohn's disease.

Tanabe H, Ito T, Inaba Y, Ando K, Nomura Y, Ueno N, Kashima S, Moriichi K, Fujiya M, Okumura T.

Eur J Radiol Open. 2017 May 5;4:58-62. doi: 10.1016/j.ejro.2017.04.003. eCollection 2017.

45.

Self-Propelled Motion of Monodisperse Underwater Oil Droplets Formed by a Microfluidic Device.

Ueno N, Banno T, Asami A, Kazayama Y, Morimoto Y, Osaki T, Takeuchi S, Kitahata H, Toyota T.

Langmuir. 2017 Jun 6;33(22):5393-5397. doi: 10.1021/acs.langmuir.7b00092. Epub 2017 May 23.

PMID:
28502179
46.

4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells.

Harao M, Forget MA, Roszik J, Gao H, Babiera GV, Krishnamurthy S, Chacon JA, Li S, Mittendorf EA, DeSnyder SM, Rockwood KF, Bernatchez C, Ueno NT, Radvanyi LG, Vence L, Haymaker C, Reuben JM.

Cancer Immunol Res. 2017 Jun;5(6):439-445. doi: 10.1158/2326-6066.CIR-16-0364. Epub 2017 May 4.

47.

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Torres-Adorno AM, Lee J, Kogawa T, Ordentlich P, Tripathy D, Lim B, Ueno NT.

Clin Cancer Res. 2017 Aug 15;23(16):4780-4792. doi: 10.1158/1078-0432.CCR-16-2622. Epub 2017 May 2.

PMID:
28465444
48.

A target of potential RELAvance in inflammatory breast cancer.

Eckhardt BL, Ueno NT.

Oncotarget. 2017 Apr 18;8(16):25835-25836. doi: 10.18632/oncotarget.17109. No abstract available.

49.

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.

Reyes ME, Fujii T, Branstetter D, Krishnamurthy S, Masuda H, Wang X, Reuben JM, Woodward WA, Edwards BJ, Hortobagyi GN, Tripathy D, Dougall WC, Eckhardt BL, Ueno NT.

Breast Cancer Res Treat. 2017 Jul;164(1):57-67. doi: 10.1007/s10549-017-4233-5. Epub 2017 Apr 17.

PMID:
28417335
50.

PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Ueno N, Nishimura N, Ueno S, Endo S, Tatetsu H, Hirata S, Hata H, Matsuoka M, Mitsuya H, Okuno Y.

Oncogene. 2017 Aug;36(31):4481-4497. doi: 10.1038/onc.2017.79. Epub 2017 Apr 3.

PMID:
28368411

Supplemental Content

Support Center